Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | SOLUTION;INTRAVENOUS | 0.002MG/ML (0.002MG/ML) | 0 | PARICALCITOL | PARICALCITOL |
002 | SOLUTION;INTRAVENOUS | 0.005MG/ML (0.005MG/ML) | 0 | PARICALCITOL | PARICALCITOL |
003 | SOLUTION;INTRAVENOUS | 0.01MG/2ML (0.005MG/ML) | 0 | PARICALCITOL | PARICALCITOL |
FDA Submissions
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
003 | Prescription | AP |
CDER Filings
SANDOZ INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91108
[companyName] => SANDOZ INC
[docInserts] => ["",""]
[products] => [{"drugName":"PARICALCITOL","activeIngredients":"PARICALCITOL","strength":"0.002MG\/ML (0.002MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PARICALCITOL","activeIngredients":"PARICALCITOL","strength":"0.005MG\/ML (0.005MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PARICALCITOL","activeIngredients":"PARICALCITOL","strength":"0.01MG\/2ML (0.005MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"PARICALCITOL","submission":"PARICALCITOL","actionType":"0.002MG\/ML (0.002MG\/ML)","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"PARICALCITOL","submission":"PARICALCITOL","actionType":"0.005MG\/ML (0.005MG\/ML)","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"PARICALCITOL","submission":"PARICALCITOL","actionType":"0.01MG\/2ML (0.005MG\/ML)","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)